Brigit Biofarmaka Teknologi Tbk. vs Satria Antaran Prima Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume), while Satria Antaran Prima Tbk. trades at Rp212 (market cap 176.67B, 79.6K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. and Satria Antaran Prima Tbk. are close in size by market cap, and Satria Antaran Prima Tbk. is more actively traded (79.6K versus 43.9K). Which is the better fit depends on your goals.
| OBAT | SAPX | |
|---|---|---|
Market Cap | 164.65B | 176.67B |
Volume | 43.9K | 79.6K |
Lot | 439 | 796 |
Turnover | 10.6M | 17.06M |
Average Price | 241.43 | 214.31 |
Value | 10.6M | 17.06M |
Indicative Equilibrium Price | 238 | — |
Indicative Equilibrium Volume | 100 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Satria Antaran Prima Tbk (the Company) was established based on Notarial Deed No. 1 ofBambang Sularso, S.H., dated July 1, 2014, notary in Jakarta.
Read more on SAPX →